Search for: "PFIZER, INC. (PFIZER)" Results 1381 - 1400 of 1,505
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 May 2015, 3:26 pm by James Galvin
The following is a list of some of the UBS Reverse Convertible Notes offered: CUSIP Issuer Product Name 90261J426 UBS Yield Optimization Notes with Contingent Protection linked to Starbucks Corp. 90261J434 UBS Yield Optimization Notes with Contingent Protection linked to Intel Corp. 90261J459 UBS Yield Optimization Notes with Contingent Protection linked to Apple, Inc. 90261J319 UBS Yield Optimization Notes with Contingent Protection linked linked to Occidental Petroleum Corp.… [read post]
9 May 2008, 10:30 pm
: (Afro-IP), (Managing Intellectual Property), Rwanda: Four years after AIDS drugs bill passed, first low cost meds may head to Rwanda: (GenericsWeb), US: Abbott’s first quarter lobbying tab hits $880,000: (Patent Docs), US: House Bill would expand federal drug pedigree requirements and preempt state requirements: (FDA Law Blog), US: Purchasing Canadian drugs and patent infringement: Litecubes decision: (Patently-O), US: Neuralstem seeks to reopen stayed patent case… [read post]
1 Apr 2015, 4:30 am
It was big news that there will be a six hour return of The X-Files, a show that dazzled us from 1993 to 2002. [read post]
23 Jan 2020, 10:37 pm by Schachtman
The phosphodiesterases 5 inhibitor medications (PDE5i) seem to arouse the litigation propensities of the lawsuit industry. [read post]
5 Jun 2013, 5:29 am by Schachtman
American Medical Systems, Inc., 958 F. [read post]
20 Jun 2023, 5:55 am by Jennifer Papapanagiotou
Food and Drug Administration (FDA) issued two Emergency Use Authorizations (EUAs) for the Pfizer, Inc. and the ModernaTX, Inc. [read post]
27 Mar 2018, 4:00 am by Michael Erdle
Pfizer Canada Inc. 2017 FC 826, the Federal Court said that the funding agreement is privileged and refused to order disclosure of the complete unredacted agreement to the defendant. [read post]
7 Apr 2008, 2:56 pm
  According to Gregg Engles, former lawyer and current CEO of Dean Foods, Inc., the discrepancy is simple. [4]  "Many lawyers let knowledge of risk paralyze them. [read post]